TY - JOUR AU - Dorn, C. R. AU - Taylor, D. O. AU - Schneider, R. AU - Hibbard, H. H. AU - Klauber, M. R. PY - 1968 DA - 1968// TI - Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County JO - J Natl Cancer Inst VL - 40 ID - Dorn1968 ER - TY - CHAP AU - Thamm, D. H. AU - Miscellaneous, T. ED - Withrow, S. J. ED - Vail, D. M. PY - 2007 DA - 2007// BT - Withrow and MacEwen's Small Animal Clinical Oncology PB - W B Saunders Co CY - St. Louis ID - Thamm2007 ER - TY - JOUR AU - Brown, N. O. AU - Patnaik, A. K. AU - MacEwen, E. G. PY - 1985 DA - 1985// TI - Canine hemangiosarcoma: retrospective analysis of 104 cases JO - J Am Vet Med Assoc VL - 186 ID - Brown1985 ER - TY - JOUR AU - Spangler, W. L. AU - Spangler, W. L. AU - Kass, P. H. AU - Kass, P. H. PY - 1997 DA - 1997// TI - Pathologic factors affecting postsplenectomy survival in dogs JO - J Vet Intern Med VL - 11 UR - https://doi.org/10.1111/j.1939-1676.1997.tb00085.x DO - 10.1111/j.1939-1676.1997.tb00085.x ID - Spangler1997 ER - TY - JOUR AU - Wood, C. A. AU - Moore, A. S. AU - Gliatto, J. M. AU - Ablin, L. A. AU - Berg, R. J. AU - Rand, W. M. PY - 1998 DA - 1998// TI - Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991–1993) JO - J Am Anim Hosp Assoc VL - 34 UR - https://doi.org/10.5326/15473317-34-5-417 DO - 10.5326/15473317-34-5-417 ID - Wood1998 ER - TY - JOUR AU - Hammer, A. S. AU - Couto, C. G. AU - Filppi, J. AU - Getzy, D. AU - Shank, K. PY - 1991 DA - 1991// TI - Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma JO - J Vet Intern Med VL - 5 UR - https://doi.org/10.1111/j.1939-1676.1991.tb00943.x DO - 10.1111/j.1939-1676.1991.tb00943.x ID - Hammer1991 ER - TY - JOUR AU - Kahn, S. A. AU - Mullin, C. M. AU - Lorimier, L. -. P. AU - Burgess, K. E. AU - Risbon, R. E. AU - Fred, R. M. PY - 2013 DA - 2013// TI - Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study JO - Canadian Veterinary J VL - 54 ID - Kahn2013 ER - TY - JOUR AU - Ogilvie, G. K. AU - Powers, B. E. AU - Mallinckrodt, C. H. AU - Withrow, S. J. PY - 1996 DA - 1996// TI - Surgery and doxorubicin in dogs with hemangiosarcoma JO - J Vet Intern Med VL - 10 UR - https://doi.org/10.1111/j.1939-1676.1996.tb02085.x DO - 10.1111/j.1939-1676.1996.tb02085.x ID - Ogilvie1996 ER - TY - JOUR AU - Sorenmo, K. AU - Duda, L. AU - Barber, L. AU - Cronin, K. AU - Sammarco, C. AU - Usborne, A. PY - 2000 DA - 2000// TI - Canine hemangiosarcoma treated with standard chemotherapy and minocycline JO - J Vet Intern Med VL - 14 UR - https://doi.org/10.1111/j.1939-1676.2000.tb02247.x DO - 10.1111/j.1939-1676.2000.tb02247.x ID - Sorenmo2000 ER - TY - JOUR AU - Sorenmo, K. U. AU - Baez, J. L. AU - Clifford, C. A. AU - Mauldin, E. AU - Overley, B. AU - Skorupski, K. PY - 2004 DA - 2004// TI - Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma JO - J Vet Intern Med VL - 18 UR - https://doi.org/10.1111/j.1939-1676.2004.tb00162.x DO - 10.1111/j.1939-1676.2004.tb00162.x ID - Sorenmo2004 ER - TY - JOUR AU - Sorenmo, K. U. AU - Jeglum, K. A. AU - Helfand, S. C. PY - 1993 DA - 1993// TI - Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide JO - J Vet Intern Med VL - 7 UR - https://doi.org/10.1111/j.1939-1676.1993.tb01033.x DO - 10.1111/j.1939-1676.1993.tb01033.x ID - Sorenmo1993 ER - TY - JOUR AU - Vail, D. M. AU - MacEwen, E. G. AU - Kurzman, I. D. AU - Dubielzig, R. R. AU - Helfand, S. C. AU - Kisseberth, W. C. PY - 1995 DA - 1995// TI - Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial JO - Clin Cancer Res VL - 1 ID - Vail1995 ER - TY - JOUR AU - U’Ren, L. W. AU - Biller, B. J. AU - Elmslie, R. E. AU - Thamm, D. H. AU - Dow, S. W. PY - 2007 DA - 2007// TI - Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma JO - J Vet Intern Med VL - 21 UR - https://doi.org/10.1111/j.1939-1676.2007.tb02936.x DO - 10.1111/j.1939-1676.2007.tb02936.x ID - U’Ren2007 ER - TY - JOUR AU - Lana, S. AU - U’ren, L. AU - Plaza, S. AU - Elmslie, R. AU - Gustafson, D. AU - Morley, P. PY - 2007 DA - 2007// TI - Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs JO - J Vet Intern Med VL - 21 UR - https://doi.org/10.1111/j.1939-1676.2007.tb03019.x DO - 10.1111/j.1939-1676.2007.tb03019.x ID - Lana2007 ER - TY - JOUR AU - Sorenmo, K. AU - Samluk, M. AU - Clifford, C. AU - Baez, J. AU - Barrett, J. S. AU - Poppenga, R. PY - 2007 DA - 2007// TI - Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma JO - J Vet Intern Med VL - 21 UR - https://doi.org/10.1111/j.1939-1676.2007.tb01958.x DO - 10.1111/j.1939-1676.2007.tb01958.x ID - Sorenmo2007 ER - TY - JOUR AU - Dickerson, E. B. AU - Marley, K. AU - Edris, W. AU - Tyner, J. W. AU - Schalk, V. AU - Macdonald, V. PY - 2013 DA - 2013// TI - Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-β and Src in Tumor Growth JO - Transl Oncol VL - 6 UR - https://doi.org/10.1593/tlo.12307 DO - 10.1593/tlo.12307 ID - Dickerson2013 ER - TY - JOUR AU - Fosmire, S. P. AU - Dickerson, E. B. AU - Scott, A. M. AU - Bianco, S. R. AU - Pettengill, M. J. AU - Meylemans, H. PY - 2004 DA - 2004// TI - Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium JO - Lab Invest VL - 84 UR - https://doi.org/10.1038/labinvest.3700080 DO - 10.1038/labinvest.3700080 ID - Fosmire2004 ER - TY - JOUR AU - Kodama, A. AU - Sakai, H. AU - Matsuura, S. AU - Murakami, M. AU - Murai, A. AU - Mori, T. PY - 2009 DA - 2009// TI - Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes JO - BMC Cancer VL - 9 UR - https://doi.org/10.1186/1471-2407-9-363 DO - 10.1186/1471-2407-9-363 ID - Kodama2009 ER - TY - JOUR AU - Lyles, S. E. AU - Milner, R. J. AU - Kow, K. AU - Salute, M. E. PY - 2012 DA - 2012// TI - In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines JO - Vet Comp Oncol VL - 10 UR - https://doi.org/10.1111/j.1476-5829.2012.00335.x DO - 10.1111/j.1476-5829.2012.00335.x ID - Lyles2012 ER - TY - JOUR AU - Tamburini, B. A. AU - Phang, T. L. AU - Fosmire, S. P. AU - Scott, M. C. AU - Trapp, S. C. AU - Duckett, M. M. PY - 2010 DA - 2010// TI - Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-619 DO - 10.1186/1471-2407-10-619 ID - Tamburini2010 ER - TY - JOUR AU - Tamburini, B. A. AU - Trapp, S. AU - Phang, T. L. AU - Schappa, J. T. AU - Hunter, L. E. AU - Modiano, J. F. PY - 2009 DA - 2009// TI - Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0005549 DO - 10.1371/journal.pone.0005549 ID - Tamburini2009 ER - TY - JOUR AU - Thamm, D. H. AU - Dickerson, E. B. AU - Akhtar, N. AU - Lewis, R. AU - Auerbach, R. AU - Helfand, S. C. PY - 2006 DA - 2006// TI - Biological and molecular characterization of a canine hemangiosarcoma-derived cell line JO - Res Vet Sci VL - 81 UR - https://doi.org/10.1016/j.rvsc.2005.09.005 DO - 10.1016/j.rvsc.2005.09.005 ID - Thamm2006 ER - TY - JOUR AU - Yonemaru, K. AU - Sakai, H. AU - Murakami, M. AU - Yanai, T. AU - Masegi, T. PY - 2006 DA - 2006// TI - Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors JO - Vet Pathol VL - 43 UR - https://doi.org/10.1354/vp.43-6-971 DO - 10.1354/vp.43-6-971 ID - Yonemaru2006 ER - TY - JOUR AU - Andersen, N. J. AU - Nickoloff, B. J. AU - Dykema, K. J. AU - Boguslawski, E. A. AU - Krivochenitser, R. I. AU - Froman, R. E. PY - 2013 DA - 2013// TI - Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-12-0893 DO - 10.1158/1535-7163.MCT-12-0893 ID - Andersen2013 ER - TY - JOUR AU - Marley, K. AU - Maier, C. S. AU - Helfand, S. C. PY - 2012 DA - 2012// TI - Phosphotyrosine enrichment identifies focal adhesion kinase and other tyrosine kinases for targeting in canine hemangiosarcoma JO - Vet Comp Oncol VL - 10 UR - https://doi.org/10.1111/j.1476-5829.2012.00325.x DO - 10.1111/j.1476-5829.2012.00325.x ID - Marley2012 ER - TY - JOUR AU - Murai, A. AU - Asa, S. A. AU - Kodama, A. AU - Hirata, A. AU - Yanai, T. AU - Sakai, H. PY - 2012 DA - 2012// TI - Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines JO - BMC Vet Res VL - 8 UR - https://doi.org/10.1186/1746-6148-8-128 DO - 10.1186/1746-6148-8-128 ID - Murai2012 ER - TY - JOUR AU - Hahn, K. A. AU - Oglivie, G. AU - Rusk, T. AU - Devauchelle, P. AU - Leblanc, A. AU - Legendre, A. PY - 2008 DA - 2008// TI - Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors JO - J Vet Intern Med VL - 22 UR - https://doi.org/10.1111/j.1939-1676.2008.0190.x DO - 10.1111/j.1939-1676.2008.0190.x ID - Hahn2008 ER - TY - JOUR AU - London, C. A. AU - Hannah, A. L. AU - Zadovoskaya, R. AU - Chien, M. B. AU - Kollias-Baker, C. AU - Rosenberg, M. PY - 2003 DA - 2003// TI - Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies JO - Clin Cancer Res VL - 9 ID - London2003 ER - TY - JOUR AU - London, C. AU - Mathie, T. AU - Stingle, N. AU - Clifford, C. AU - Haney, S. AU - Klein, M. K. PY - 2012 DA - 2012// TI - Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours JO - Vet Comp Oncol VL - 10 UR - https://doi.org/10.1111/j.1476-5829.2011.00275.x DO - 10.1111/j.1476-5829.2011.00275.x ID - London2012 ER - TY - JOUR AU - London, C. A. AU - Malpas, P. B. AU - Wood-Follis, S. L. AU - Boucher, J. F. AU - Rusk, A. W. AU - Rosenberg, M. P. PY - 2009 DA - 2009// TI - Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1860 DO - 10.1158/1078-0432.CCR-08-1860 ID - London2009 ER - TY - JOUR PY - 2004 DA - 2004// TI - Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0 JO - Vet Comp Oncol VL - 2 UR - https://doi.org/10.1111/j.1476-5810.2004.0053b.x DO - 10.1111/j.1476-5810.2004.0053b.x ID - ref31 ER - TY - JOUR AU - Göritz, M. AU - Müller, K. AU - Krastel, D. AU - Staudacher, G. AU - Schmidt, P. AU - Kühn, M. PY - 2013 DA - 2013// TI - Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors JO - J Comp Pathol VL - 149 UR - https://doi.org/10.1016/j.jcpa.2012.11.234 DO - 10.1016/j.jcpa.2012.11.234 ID - Göritz2013 ER - TY - STD TI - Abou Asa S, Mori T, Maruo K, Khater A, sawak El A, Abd el Aziz E, Yanai T, Sakai H: Analysis of genomic mutation and immunohistochemistry of platelet‐derived growth factor receptors in canine vascular tumours. Veterinary and Comparative Oncology 2013. doi:10.1111/vco.12035. ID - ref33 ER - TY - JOUR AU - Pàez-Ribes, M. AU - Allen, E. AU - Hudock, J. AU - Takeda, T. AU - Okuyama, H. AU - Viñals, F. PY - 2009 DA - 2009// TI - Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis JO - Cancer Cell VL - 15 UR - https://doi.org/10.1016/j.ccr.2009.01.027 DO - 10.1016/j.ccr.2009.01.027 ID - Pàez-Ribes2009 ER - TY - JOUR AU - Ebos, J. M. L. AU - Lee, C. R. AU - Cruz-Munoz, W. AU - Bjarnason, G. A. AU - Christensen, J. G. AU - Kerbel, R. S. PY - 2009 DA - 2009// TI - Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis JO - Cancer Cell VL - 15 UR - https://doi.org/10.1016/j.ccr.2009.01.021 DO - 10.1016/j.ccr.2009.01.021 ID - Ebos2009 ER - TY - JOUR AU - Singh, M. AU - Couto, S. S. AU - Forrest, W. F. AU - Lima, A. AU - Cheng, J. H. AU - Molina, R. PY - 2012 DA - 2012// TI - Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models JO - J Pathol VL - 227 UR - https://doi.org/10.1002/path.4053 DO - 10.1002/path.4053 ID - Singh2012 ER - TY - JOUR AU - Blagoev, K. B. AU - Wilkerson, J. AU - Stein, W. D. AU - Motzer, R. J. AU - Bates, S. E. AU - Fojo, A. T. PY - 2013 DA - 2013// TI - Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma JO - Cell Rep VL - 3 UR - https://doi.org/10.1016/j.celrep.2013.01.015 DO - 10.1016/j.celrep.2013.01.015 ID - Blagoev2013 ER - TY - JOUR AU - Kadenhe-Chiweshe, A. AU - Papa, J. AU - McCrudden, K. W. AU - Frischer, J. AU - Bae, J. -. O. AU - Huang, J. PY - 2008 DA - 2008// TI - Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation JO - Mol Cancer Res VL - 6 UR - https://doi.org/10.1158/1541-7786.MCR-07-0101 DO - 10.1158/1541-7786.MCR-07-0101 ID - Kadenhe-Chiweshe2008 ER - TY - JOUR AU - Inai, T. AU - Mancuso, M. AU - Hashizume, H. AU - Baffert, F. AU - Haskell, A. AU - Baluk, P. PY - 2004 DA - 2004// TI - Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts JO - Am J Pathol VL - 165 UR - https://doi.org/10.1016/S0002-9440(10)63273-7 DO - 10.1016/S0002-9440(10)63273-7 ID - Inai2004 ER - TY - JOUR AU - Mancuso, M. R. AU - Davis, R. AU - Norberg, S. M. AU - O’Brien, S. AU - Sennino, B. AU - Nakahara, T. PY - 2006 DA - 2006// TI - Rapid vascular regrowth in tumors after reversal of VEGF inhibition JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI24612 DO - 10.1172/JCI24612 ID - Mancuso2006 ER - TY - JOUR AU - Chung, A. S. AU - Wu, X. AU - Zhuang, G. AU - Ngu, H. AU - Kasman, I. AU - Zhang, J. PY - 2013 DA - 2013// TI - An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3291 DO - 10.1038/nm.3291 ID - Chung2013 ER - TY - JOUR AU - Seghezzi, G. AU - Patel, S. AU - Ren, C. J. AU - Gualandris, A. AU - Pintucci, G. AU - Robbins, E. S. PY - 1998 DA - 1998// TI - Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis JO - J Cell Biol VL - 141 UR - https://doi.org/10.1083/jcb.141.7.1659 DO - 10.1083/jcb.141.7.1659 ID - Seghezzi1998 ER - TY - JOUR AU - Bernabe, L. F. AU - Portela, R. AU - Nguyen, S. AU - Kisseberth, W. C. AU - Pennell, M. AU - Yancey, M. F. PY - 2013 DA - 2013// TI - Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose JO - BMC Vet Res VL - 9 UR - https://doi.org/10.1186/1746-6148-9-190 DO - 10.1186/1746-6148-9-190 ID - Bernabe2013 ER - TY - JOUR AU - Lee, K. AU - Qian, D. Z. AU - Rey, S. AU - Wei, H. AU - Liu, J. O. AU - Semenza, G. L. PY - 2009 DA - 2009// TI - Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0812801106 DO - 10.1073/pnas.0812801106 ID - Lee2009 ER - TY - STD TI - Pan X, Tsimbas K, Kurzman ID, Vail DM: Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia(®)) in tumour-bearing dogs: a phase I dose-finding study. Veterinary and Comparative Oncology 2014. doi:10.1111/vco.12091. ID - ref45 ER - TY - JOUR AU - Robat, C. AU - London, C. AU - Bunting, L. AU - McCartan, L. AU - Stingle, N. AU - Selting, K. PY - 2012 DA - 2012// TI - Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study JO - Vet Comp Oncol VL - 10 UR - https://doi.org/10.1111/j.1476-5829.2011.00261.x DO - 10.1111/j.1476-5829.2011.00261.x ID - Robat2012 ER -